HealthCare Global Enterprises Ltd.

HealthCare Global Enterprises Ltd.

551.15
INR
+0.50
(+0.09%)
2.31EPS
395.72P/E
93.63BMarket Cap
Nov 05Next Earn
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
73.8
79.67
81.08
94.51
108.63
121.28
87.8
105.98
119.77
134.9
156.93
178.54
182.26
Basic EPS, GAAP
0.12
-0.2
2.59
2.37
-2.8
-11.98
-16.92
4.12
2.1
3.44
3.17
0.97
1.58
Free Cash Flow per Basic Share
8.48
-18.7
-11.83
-18.29
-10.21
2.51
7.44
11.41
8.46
7.06
7.72
3.89
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
21.29
49.74
50.17
58.91
53.88
42.72
55.27
62.22
61.48
58.92
65.76
89.21
- -
Tangible Book Value per Share
12.31
42.32
42.32
45.74
40.47
26.88
45.93
47.13
47.19
39.68
30.44
59.95
- -
Basic Weighted Avg Shares
70
73
86
87
88
89
114
131
140
140
140
141
144
Sales/Revenue/Turnover
5,194
5,842
6,948
8,183
9,609
10,806
10,040
13,831
16,760
18,899
22,008
25,222
26,200
Operating Margin (%)
7.13
7.01
6.94
7.02
4.18
2.43
-3.25
5.81
10.04
8.33
8.48
8.79
8.53
Depreciation Expense
399
446
568
715
851
1,484
1,592
1,583
1,635
1,744
2,113
2,442
2,567
Net Income, GAAP
8
-15
222
205
-248
-1,067
-1,935
537
293
482
444
138
228
Effective Tax Rate (%)
- -
- -
33.87
37.67
- -
- -
- -
55.65
60.72
38.97
14.27
15.37
16.91
Profit Margin (%)
0.16
-0.25
3.19
2.51
-2.58
-9.87
-19.27
3.88
1.75
2.55
2.02
0.55
0.87
Working Capital
-712
-355
-1,214
-1,387
-2,744
-2,720
-303
326
100
-639
-2,026
1,180
- -
LT Debt
2,659
2,458
2,834
3,724
5,169
11,388
8,155
8,288
8,148
10,441
13,797
13,592
- -
Total Equity
2,075
4,585
4,901
5,790
5,222
4,198
7,140
8,837
8,694
8,651
9,900
14,102
- -
Return on Invested Capital (%)
- -
- -
3.85
3.83
- -
- -
- -
4.48
3.01
5.1
6.37
5.39
- -
Return on Capital (%)
- -
- -
4.08
4.83
- -
- -
- -
6.13
4.38
5.96
6.67
4.91
- -
Return on Common Equity (%)
- -
-0.48
5.17
4.33
-5
-24.87
-35.88
6.86
3.39
5.71
5.08
1.22
- -

Capital Structure

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
3,762
- -
LT Borrowings
- -
5,992
- -
LT Finance Leases
- -
7,600
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
142
149
149
Market Capitalization
93,347
78,414
93,627

Working Capital

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
- -
11,352
- -
Cash, Cash Equivalents & STI
- -
5,428
- -
Accounts Receivable, Net
- -
4,207
- -
Inventories
- -
598
- -
Total Current Liabilities
- -
10,172
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
3,762
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
14.42%
15.71%
42.44%
Free Cash Flow
14.18%
-0.35%
-49.2%
Net Income, GAAP
-162.02%
-37.18%
-69.03%
Sales/Revenue/Turnover
16.23%
20.55%
14.6%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
5,247
5,525
5,576
5,834
22,008
2026
6,118
6,452
6,312
6,503
25,222
2027
6,934
- -
- -
- -
- -

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
0.86
1.28
0.5
0.52
3.17
2026
0.34
1.15
-0.68
0.15
0.97
2027
0.92
- -
- -
- -
- -

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
2027
- -
- -
- -
- -
- -

Company Description

CEO
Manish Mattoo
Full Time Employees
8,355
Sector
Health services
Industry
Hospital/Nursing management
Address
Unity Building Complex Bangalore KA India 560027
IPO Date
Mar 30, 2016
Business
HealthCare Global Enterprises Limited (HCG) operates as India's largest provider of cancer care services through a network of 22 comprehensive cancer centers, multispecialty hospitals, fertility clinics, and diagnostic facilities. The company offers specialized oncology treatments including chemotherapy, radiotherapy, surgical oncology, precision medicine, robotic surgery, and palliative care under the HCG brand; multispecialty tertiary care services via HCG Hospitals; infertility treatments through seven Milann fertility centers; and advanced diagnostic screening with Triesta Sciences, encompassing scientific testing, consultancy, and multi-omic analysis. These services utilize cutting-edge technologies such as proton therapy, AI-driven image analysis, and clinical research protocols, supported by over 275 oncologists, and target patients across urban, Tier II/III cities, and rural areas in India, with additional operations in South Asia and a comprehensive cancer center in Nairobi, Kenya. Founded effectively in 1989 with its first dedicated cancer hospital in 2000 and formally incorporated in 1998, HCG maintains headquarters at HCG Tower, No. 8 P. Kalinga Rao Road, Sampangi Rama Nagar, Bangalore, Karnataka 560027, India. Recent developments include a December 2024 strategic collaboration with Accenture to leverage generative AI, deep learning, and quantum computing for accelerating cancer research, early detection, and precision medicine in lung adenocarcinoma and head and neck cancers; approval in November 2025 for up to Rs. 700 lakh in equity investments; robust financial performance with Q2 FY26 revenue of Rs. 6,470 million (up 16.9% year-over-year) and adjusted EBITDA of Rs. 1,233 million; and ongoing ownership transitions highlighted by CVC Capital Partners' agreement in February 2025 to sell up to a 54% stake to KKR at INR 445 per share, alongside plans for network expansion into additional centers.